HUTCHMED (China) Ltd (HCM)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

199.50p

Buy

204.00p

arrow-down-5.00p (-2.45%)

Prices updated at 19 Dec 2025, 16:40 GMT

Prices minimum 15 mins delay

Prices in GBX

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Dan Eldar

CEO

Mr. Johnny Cheng Chig FUNG

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

1,811

Head office

2 Queen's Road Central

Hong Kong

+852 2121 8200

ir@chi-med.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Professor Shu Kam Tony Mok Non-Executive Director, Senior Independent Director	-
Ms. Edith Shih Non-Executive Director, Company Secretary	-
Mr. Dan Eldar Non-Executive Director, Chairman	-
Dr. Renu Bhatia Non-Executive Director	-
Mr. Johnny Cheng Chig FUNG Executive Director, Acting Chief Executive Officer and Chief Financial Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
AEGON-Industrial Fund Mgmt Co.,Ltd	19,850,648
AIFMC HeYi Alloc(LOF)	14,486,500
Vanguard Group Inc	14,270,028
GF Fund Mgmt Co.,Ltd	10,615,500
GF CSI Hong Kong Brand Nm Drug ETF(QDII)	10,571,500

Director dealings

Date chevron-l-regular chevron-r-regular	Action
20 Oct 2025	Transfer in
20 Oct 2025	Transfer in
13 Mar 2025	Transfer in

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.